Prognostic Value of Exercise Capacity in Kidney Transplant Candidates.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
21 06 2022
Historique:
pubmed: 15 6 2022
medline: 24 6 2022
entrez: 14 6 2022
Statut: ppublish

Résumé

Background Exercise stress testing for cardiovascular assessment in kidney transplant candidates has been shown to be a feasible alternative to pharmacologic methods. Exercise stress testing allows the additional assessment of exercise capacity, which may have prognostic value for long-term cardiovascular outcomes in pre-transplant recipients. This study aimed to evaluate the prognostic value of exercise capacity on long-term cardiovascular outcomes in kidney transplant candidates. Methods and Results We retrospectively evaluated exercise capacity in 898 consecutive kidney transplant candidates between 2013 and 2020 who underwent symptom-limited exercise stress echocardiography for pre-transplant cardiovascular assessment. Exercise capacity was measured by age- and sex-predicted metabolic equivalents (METs). The primary outcome was incident major adverse cardiovascular events, defined as cardiac death, non-fatal myocardial infarction, and stroke. Cox proportional hazard multivariable modeling was performed to define major adverse cardiovascular events predictors with transplantation treated as a time-varying covariate. A total of 429 patients (48%) achieved predicted METs. During follow-up, 93 (10%) developed major adverse cardiovascular events and 525 (58%) underwent transplantation. Achievement of predicted METs was independently associated with reduced major adverse cardiovascular events (hazard ratio [HR] 0.49; [95% CI 0.29-0.82],

Identifiants

pubmed: 35699178
doi: 10.1161/JAHA.121.025862
pmc: PMC9238638
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e025862

Références

Transplantation. 2020 Apr;104(4S1 Suppl 1):S11-S103
pubmed: 32301874
JACC Cardiovasc Imaging. 2020 Dec;13(12):2485-2494
pubmed: 32861659
Nephrol Dial Transplant. 2001 Aug;16(8):1545-9
pubmed: 11477152
J Am Soc Nephrol. 2014 Jan;25(1):187-95
pubmed: 24231666
Am J Kidney Dis. 2014 Sep;64(3):383-93
pubmed: 24913219
Clin Transplant. 2016 Oct;30(10):1209-1215
pubmed: 27327660
J Am Coll Cardiol. 2021 Jul 27;78(4):348-361
pubmed: 33989711
Circulation. 2018 Feb 27;137(9):961-972
pubmed: 29483172
Circulation. 2003 Jan 7;107(1):87-92
pubmed: 12515748
Kidney Int. 2004 Feb;65(2):719-24
pubmed: 14717947
Circulation. 2014 Dec 9;130(24):2215-45
pubmed: 25085962
Am J Kidney Dis. 2015 Aug;66(2):274-84
pubmed: 25900597
J Am Heart Assoc. 2018 May 31;7(11):
pubmed: 29853444
N Engl J Med. 2020 Apr 9;382(15):1408-1419
pubmed: 32227753
N Engl J Med. 2020 Apr 23;382(17):1608-1618
pubmed: 32227756
J Am Coll Cardiol. 1995 Jul;26(1):18-25
pubmed: 7797748
Eur Heart J. 2009 Nov;30(22):2769-812
pubmed: 19713421
Am Heart J. 2019 Aug;214:175-183
pubmed: 31228771
J Am Coll Cardiol. 2015 Nov 10;66(19):2140-2148
pubmed: 26541926
J Am Soc Echocardiogr. 2007 Sep;20(9):1021-41
pubmed: 17765820
Circulation. 2012 Jul 31;126(5):617-63
pubmed: 22753303
Am J Nephrol. 2013;38(4):307-15
pubmed: 24107579
Am J Kidney Dis. 2021 Apr;77(4 Suppl 1):A7-A8
pubmed: 33752804
J Am Coll Cardiol. 2007 Nov 6;50(19):1867-75
pubmed: 17980254
Am J Transplant. 2008 Aug;8(8):1673-83
pubmed: 18510627

Auteurs

Sean Tan (S)

Monash Cardiovascular Research Centre, Victorian Heart Institute Monash University Melbourne Victoria Australia.
Monash Heart Monash Health Melbourne Victoria Australia.

Yi Wen Thang (YW)

Department of Nephrology Monash Health Melbourne Victoria Australia.

William R Mulley (WR)

Department of Nephrology Monash Health Melbourne Victoria Australia.
Department of Medicine Monash University Melbourne Victoria Australia.

Kevan R Polkinghorne (KR)

Department of Nephrology Monash Health Melbourne Victoria Australia.
Department of Medicine Monash University Melbourne Victoria Australia.

Satish Ramkumar (S)

Monash Cardiovascular Research Centre, Victorian Heart Institute Monash University Melbourne Victoria Australia.
Monash Heart Monash Health Melbourne Victoria Australia.

Kevin Cheng (K)

Monash Cardiovascular Research Centre, Victorian Heart Institute Monash University Melbourne Victoria Australia.
Monash Heart Monash Health Melbourne Victoria Australia.

Jasmine Chan (J)

Monash Cardiovascular Research Centre, Victorian Heart Institute Monash University Melbourne Victoria Australia.
Monash Heart Monash Health Melbourne Victoria Australia.

John Galligan (J)

Monash Cardiovascular Research Centre, Victorian Heart Institute Monash University Melbourne Victoria Australia.
Monash Heart Monash Health Melbourne Victoria Australia.

Mark Nolan (M)

Baker Heart and Diabetes Institute Melbourne Victoria Australia.

Adam J Brown (AJ)

Monash Cardiovascular Research Centre, Victorian Heart Institute Monash University Melbourne Victoria Australia.
Monash Heart Monash Health Melbourne Victoria Australia.

Stuart Moir (S)

Monash Cardiovascular Research Centre, Victorian Heart Institute Monash University Melbourne Victoria Australia.
Monash Heart Monash Health Melbourne Victoria Australia.

James D Cameron (JD)

Monash Cardiovascular Research Centre, Victorian Heart Institute Monash University Melbourne Victoria Australia.

Stephen J Nicholls (SJ)

Monash Cardiovascular Research Centre, Victorian Heart Institute Monash University Melbourne Victoria Australia.
Monash Heart Monash Health Melbourne Victoria Australia.

Philip M Mottram (PM)

Monash Cardiovascular Research Centre, Victorian Heart Institute Monash University Melbourne Victoria Australia.
Monash Heart Monash Health Melbourne Victoria Australia.

Nitesh Nerlekar (N)

Monash Cardiovascular Research Centre, Victorian Heart Institute Monash University Melbourne Victoria Australia.
Monash Heart Monash Health Melbourne Victoria Australia.
Baker Heart and Diabetes Institute Melbourne Victoria Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH